Clinical trial
Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for…
NCT00241215 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00241215 |
|---|---|
| Title | Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome |
| Official title | Probe Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | Allergan Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cervicobrachial Neuralgia, Myofascial Pain Syndromes |
| Intervention type | Drug |
| Interventions | Botulinum toxin serotype A |
| Enrollment | 132 |
| Start date | Jun 1, 2003 |
| Primary completion | Nov 1, 2005 |
| First posted | Oct 18, 2005 |
| Last update posted | Jun 21, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: